CELLECTAR BIOSCIENCES, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.41 USD | +1.49% |
|
+5.71% | +23.65% |
| 05-14 | Transcript : Cellectar Biosciences, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
| 05-14 | Cellectar Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Cellectar Biosciences, Inc.
2aa3518fa807f382bc2a1211.1491gOtIEb3JaQTZbRxWrFB3lJrm75cp3YcMmjD-9iM.iNkU7bsPSNWQGFKePG093ScYx_2PiP1Akd18qAStzg7nuRnyvj9D_6sBaw~033ac759c0e77e6a8d21eb9559fd8ef7
Upcoming events on Cellectar Biosciences, Inc.
Past events on Cellectar Biosciences, Inc.
| 14/05/2024 13:30 | Q1 2024 Earnings Call |
| 14/05/2024 11:40 | Q1 2024 Earnings Release |
| 13/05/2024 18:00 | Guggenheim Securities Radiopharmaceuticals Day |
| 27/03/2024 12:30 | Q4 2023 Earnings Call |
| 27/03/2024 10:40 | Q4 2023 Earnings Release |
| 19/03/2024 16:00 | Roth Conference |
| 19/03/2024 16:00 | Roth Conference |
| 14/02/2024 19:00 | Oppenheimer Healthcare Life Sciences Conference |
| 19/01/2024 13:30 | Investor Meeting - Key Opinion Leader |
| 09/01/2024 22:00 | Biotech Showcase |
| 08/01/2024 13:00 | Iopofosine I 131 Trial Results Call |
| 07/01/2024 | JPMorgan Healthcare Conference |
| 07/12/2023 10:30 | Targeted Radiopharmaceuticals Summit |
| 02/11/2023 12:30 | Q3 2023 Earnings Call |
| 02/11/2023 11:30 | Q3 2023 Earnings Release |
| 25/10/2023 15:00 | Extraordinary Shareholders Meeting |
| 14/08/2023 13:40 | Q2 2023 Earnings Release |
| 25/06/2023 | Society of Nuclear Medicine and Molecular Imaging Meeting - Abstract No #P1243 |
| 23/06/2023 15:00 | Annual General Meeting |
| 04/05/2023 13:40 | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -14,2 -14,3 0.77% | -15,3 -15,8 3.16% | -24,1 -24,5 1.5% | -28,8 -29,7 3.12% | -39,0 -35,4 -9.93% | -51,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -14,1 -14,1 0.08% | -15,1 -15,7 3.8% | -24,1 -24,5 1.49% | -28,7 -29,7 3.4% | -38,0 -40,0 4.97% | -46,6 |
|
Net income Million USD | Released Forecast Spread | -14,1 -14,2 0.63% | -15,1 -15,7 3.91% | -24,1 -24,5 1.4% | -28,6 -29,7 3.81% | -38,0 -36,3 -4.5% | -65,4 |
|
EPS USD | Released Forecast Spread | -18,4 -18,9 2.77% | -7,60 -8,20 7.32% | -4,30 -4,43 2.82% | -4,05 -3,31 -22.54% | -3,11 -2,62 -18.59% | -1,89 |
| Announcement Date | 09/03/20 | 02/03/21 | 21/03/22 | 09/03/23 | 27/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 3,00 |
|
EBIT Million USD | Released Forecast Spread | -6,14 -6,38 3.72% | -7,44 -6,36 -16.95% | -7,82 -7,72 -1.25% | -7,42 -8,35 11.11% | -8,71 -7,64 -13.92% | -8,29 -7,81 -6.19% | -9,41 -8,53 -10.31% | -12,5 -9,47 -32.46% | 12,0 -13,3 190.02% | -13,1 | -14,5 | -16,2 | -17,5 | -15,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -6,14 -6,15 0.15% | -7,44 -6,24 -19.11% | -7,81 -7,38 -5.91% | -7,28 -8,29 12.19% | -8,58 -8,06 -6.53% | -8,22 -8,37 1.77% | -13,7 -9,12 -50.52% | -7,51 -9,50 20.94% | -21,6 -12,8 -68.45% | -13,1 | -13,4 | -14,0 | ||
|
Net income Million USD | Released Forecast Spread | -6,14 -6,38 3.72% | -7,44 -6,36 -16.94% | -7,81 -7,66 -1.92% | -7,22 -8,35 13.54% | -8,58 -7,64 -12.34% | -8,22 -7,80 -5.47% | -13,7 -8,53 -60.92% | -7,45 -9,24 19.38% | -21,6 -13,3 -61.9% | -13,1 | -14,5 | -16,2 | -17,5 | -15,4 |
|
EPS USD | Released Forecast Spread | -1,00 -1,00 0% | -1,22 -1,04 -17.87% | -1,28 -1,26 -1.86% | -0,55 -1,08 48.84% | -0,76 -0,87 12.39% | -0,73 -0,67 -9.77% | -1,21 -0,45 -171.91% | -0,40 -0,53 24.53% | -0,74 -0,56 -31.36% | -0,37 | -0,37 | -0,41 | -0,50 | -0,40 |
| Announcement Date | 10/05/22 | 05/08/22 | 03/11/22 | 09/03/23 | 04/05/23 | 14/08/23 | 13/11/23 | 27/03/24 | 14/05/24 | - | - | - | - | - |
More events
Past sector events for Cellectar Biosciences, Inc.
| 14/05/2024 | MANKIND PHARMA LIMITED: Q4 2024 Earnings Release |
| 14/05/2024 | CRESCO LABS INC.: Q1 2024 Earnings Release |
| 14/05/2024 | GRANULES INDIA LIMITED: Q4 2024 Earnings Release |
| 14/05/2024 | EISAI CO., LTD.: Q4 2023 Earnings Release |
| 14/05/2024 | DERMAPHARM HOLDING SE: Q1 2024 Earnings Release |
| 14/05/2024 22:43 | LIQUIDIA CORPORATION: Q1 2024 Earnings Release |
| 14/05/2024 09:52 | BORA PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release |
| 14/05/2024 06:30 | BAYER AG: Q1 2024 Earnings Release |
| 13/05/2024 | SAUDI PHARMACEUTICAL INDUSTRIES AND MEDICAL APPLIANCES CORPORATION: Q1 2024 Earnings Release (Projected) |
| 14/05/2024 22:00 | PRESTIGE CONSUMER HEALTHCARE INC.: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CLRB Stock
- Calendar Cellectar Biosciences, Inc.
